Elevance Health $1.8 billion senior notes offering
The investment-grade notes are due 2025, 2032 and 2052
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
Recursion Pharmaceuticals $150 million private placement
We advised the placement agents on the private placement of common stock
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Immatics $110 million follow-on offering
We advised Immatics on the offering of shares
Gamida Cell $20 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Solid Biosciences $75 million common stock PIPE offering
The financing is taking place concurrently with the company’s acquisition of AavantiBio
EDAP TMS $23 million follow-on offering
The ADSs are listed on the Nasdaq Global Market